Erythropoietin augments survival of glioma cells after radiation and 
temozolomide

Hassouna, Imam; Sperling, Swetlana; Kim, Ella; Schulz-Schaeffer, Walter; Rave-Fränk, Margret; Hasselblatt, Martin; Jelkmann, Wolfgang; Giese, Alf; Ehrenreich, Hannelore

doi:10.1016/j.ijrobp.2008.06.1923

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Erythropoietin augments survival of glioma cells after radiation and temozolomide

MPS-Authors

/persons/resource/persons182183

Hassouna, Imam
Clinical neuroscience, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182422

Sperling, Swetlana
Clinical neuroscience, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182182

Hasselblatt, Martin
Clinical neuroscience, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182138

Ehrenreich, Hannelore
Clinical neuroscience, Max Planck Institute of Experimental Medicine, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Hassouna, I., Sperling, S., Kim, E., Schulz-Schaeffer, W., Rave-Fränk, M., Hasselblatt, M., et al. (2008). Erythropoietin augments survival of glioma cells after radiation and temozolomide. International Journal of Radiation Oncology, Biology, Physics, 72(3), 927-934. doi:10.1016/j.ijrobp.2008.06.1923.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002A-2955-6

Abstract

There is no abstract available